Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccinations01:51

Vaccinations

Overview
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the Reduction of Recurrent Admissions Using OM-85 for the Treatment of Preschool Wheeze (ARROW): Protocol for a Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Trial.

Journal of paediatrics and child health·2026
Same author

Recreational Drug Use Amongst Children and Adolescents Presenting to Australian Emergency Departments With Acute Behavioural Disturbance: A Secondary Analysis of a Randomised Controlled Trial.

Emergency medicine Australasia : EMA·2026
Same author

Giant Cell Arteritis Following COVID-19 Vaccination: A Consumer-Stimulated Analysis.

Drug safety·2026
Same author

Multiple imputation in clinical trials - what difference does it make?: A systematic review of the impact of multiple imputation on treatment effect estimation.

Clinical trials (London, England)·2026
Same author

Inverse probability weighted estimation of dynamic treatment regimen means in sequential multiple assignment randomised trials with missing data: a simulation study.

Trials·2026
Same author

Skin microbiome composition and function in the development of atopic diseases during infancy.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: May 31, 2026

Assessing Respiratory Immune Responses to Haemophilus Influenzae
06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

Recurrent apnoea post immunisation: Informing re-immunisation policy.

Vanessa Clifford1, Nigel W Crawford, Jenny Royle

  • 1SAEFVIC, Murdoch Children's Research Institute, Melbourne, Australia. vanessa.clifford@rch.org.au

Vaccine
|June 23, 2011
PubMed
Summary

Preterm infants experiencing apnoea after immunisation have an 18% recurrence risk. Lower birth weight and prematurity complications are risk factors, but a third episode is unlikely. Monitoring is recommended.

More Related Videos

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)
13:00

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)

Published on: July 31, 2021

Related Experiment Videos

Last Updated: May 31, 2026

Assessing Respiratory Immune Responses to Haemophilus Influenzae
06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)
13:00

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)

Published on: July 31, 2021

Area of Science:

  • Neonatalogy
  • Pediatric Vaccinology
  • Public Health Surveillance

Background:

  • Routine immunizations are recommended based on chronological age, but concerns about adverse events following immunization (AEFI) in preterm infants often lead to delays.
  • Apnoea with or without bradycardia temporally associated with immunisation (AEFI) can occur in a small number of infants, with unknown risk factors and recurrence rates.
  • This uncertainty complicates immunization planning for vulnerable preterm infants.

Purpose of the Study:

  • To determine the recurrence rates of immunisation-associated apnoea in preterm and term infants.
  • To identify potential risk factors for recurrent apnoea in preterm infants following immunisation.

Main Methods:

  • A retrospective analysis of apnoea +/- bradycardia AEFIs reported to SAEFVIC in Victoria, Australia, from May 2007 to April 2010.
  • Included preterm and term infants; apnoea was defined as occurring up to 48 hours post-immunisation.

Main Results:

  • 18% (7/38) of preterm infants with initial apnoea experienced recurrence with subsequent immunisations.
  • Lower birth weight and ongoing hospitalisation for prematurity complications were identified as risk factors for recurrence (p=0.04 and p=0.01, respectively).
  • No preterm infant experienced a third episode; no term infants showed recurrence.

Conclusions:

  • A significant risk of recurrent apnoea exists in preterm infants following immunisation.
  • Preterm infants with post-immunisation apnoea should undergo cardio-respiratory monitoring for at least 24 hours after subsequent vaccinations.